Pyxis Oncology PYXS
NASDAQ PYXS
$1.68 -0.03 (-1.75%)
At close: Oct 23, 2026 · 4:00 PM EDT

Pyxis Oncology (PYXS) Other Accumulated Expenses (2020 - 2025)

Updated

Pyxis Oncology (PYXS) recorded Other Accumulated Expenses of $4 million in Q4 2025, down 37.2% from $6.37 million a year earlier.

Analysis

Pyxis Oncology (PYXS) Other Accumulated Expenses (2020 - 2025) Analysis & Trends

Starting with Q4 2020, Pyxis Oncology's Other Accumulated Expenses history includes 6 quarters.

  • Annual Other Accumulated Expenses has declined for three straight years, though with a five-year compound annual growth rate of 41.2% (FY2020 to FY2025).
  • Across earlier years, Other Accumulated Expenses came in at $6.37 million in FY2024 (-3.5%), $6.59 million in FY2023 (-62.1%), $17.41 million in FY2022 (+631.4%) and $2.38 million in FY2021 (+234.4%).
  • The Q4 2025 figure is the lowest quarterly Other Accumulated Expenses since Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Pyxis Oncology 107.83 Mn -157.23 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 4.00 Mn
Dec 31, 2024 6.37 Mn
Dec 31, 2023 6.59 Mn
Dec 31, 2022 17.41 Mn
Dec 31, 2021 2.38 Mn
Dec 31, 2020 712,000.00
API Access

Pyxis Oncology Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=PYXS&period=max&api_key=YOUR_API_KEY